<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - MRK</title>
<description>International Business News - MRK</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Schering-Plough CEO says rebuilding plan on track</title>
  <description>Schering-Plough Corp.'s chief executive told shareholders Friday the company remains on track five years into his rebuilding program, with a wider range of products and more drugs in late-stage development.</description>
    <link>http://www.ibtimes.com/articles/20080516/schering-plough-ceo-says-rebuilding-plan-on-track.htm</link> 
  <pubDate>Fri, 16 May 2008 17:01:12 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Pharmaceuticals</title>
  <description>Shares of large pharmaceutical companies lacked direction in early Friday trading. The broader market slipped as investors digested new record highs for oil and a surprising jump in new home construction.</description>
    <link>http://www.ibtimes.com/articles/20080516/opening-glance-pharmaceuticals.htm</link> 
  <pubDate>Fri, 16 May 2008 09:54:34 EDT</pubDate>
  </item>


  <item>
  <title>Dynavax shares plummet on allergy drug failure</title>
  <description>Shares of Dynavax Technologies Corp. plummeted Friday after the drug developer said it is ending development of its ragweed allergy drug Tolamba after it failed a midstage trial.</description>
    <link>http://www.ibtimes.com/articles/20080516/dynavax-ends-development-of-allergy-drug-tolamba.htm</link> 
  <pubDate>Fri, 16 May 2008 09:52:15 EDT</pubDate>
  </item>


  <item>
  <title>Geron shares recover after drop on study delay</title>
  <description>Shares of biotechnology company Geron Corp. regained some ground Thursday, following a prior-day plunge on the Food and Drug Administration's decision to place a clinical hold on a planned stem-cell study.</description>
    <link>http://www.ibtimes.com/articles/20080515/geron-shares-recover-after-drop-on-study-delay.htm</link> 
  <pubDate>Thu, 15 May 2008 17:55:45 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Pharmaceuticals</title>
  <description>Shares of large pharmaceutical companies closed mostly higher Thursday as the broader market gained ground on falling oil prices and better-than-expected economic data.</description>
    <link>http://www.ibtimes.com/articles/20080515/closing-glance-pharmaceuticals.htm</link> 
  <pubDate>Thu, 15 May 2008 16:33:59 EDT</pubDate>
  </item>


  <item>
  <title>People over 60 urged to get one-time shingles shot</title>
  <description>People 60 and older should get a one-time shingles shot that can help prevent the painful rash, U.S. health officials are recommending. There's a 50-50 chance the shot will prevent shingles for those 60 and up, though the odds get worse the older you get. But shingles can be severe for some people, and the government believes it's worth the $160-per-dose cost.</description>
    <link>http://www.ibtimes.com/articles/20080515/people-over-60-urged-to-get-one-time-shingles-shot.htm</link> 
  <pubDate>Thu, 15 May 2008 15:19:56 EDT</pubDate>
  </item>


  <item>
  <title>Shingles shots urged for those 60 and up, US says</title>
  <description>People 60 and older should get a one-time shingles shot that can help prevent the painful rash, U.S. health officials are recommending. There's a 50-50 chance the shot will prevent shingles for those 60 and up, though the odds get worse the older you get. But shingles can be severe for some people, and the government believes it's worth the $160-per-dose cost.</description>
    <link>http://www.ibtimes.com/articles/20080515/shingles-shots-urged-for-those-60-and-up-us-says.htm</link> 
  <pubDate>Thu, 15 May 2008 15:09:18 EDT</pubDate>
  </item>


  <item>
  <title>TV drug ads may have to zoom in on side effects</title>
  <description>Would consumers get the same warm, fuzzy message from a drug advertisement that promised to lift their mood if it also urged them to report side effects like suicidal thoughts and diarrhea?</description>
    <link>http://www.ibtimes.com/articles/20080515/tv-drug-ads-may-have-to-zoom-in-on-side-effects.htm</link> 
  <pubDate>Thu, 15 May 2008 14:11:05 EDT</pubDate>
  </item>


  <item>
  <title>Merck shingles vaccine gets CDC recommendation</title>
  <description>Merck &amp; Co. said Thursday the U.S. Centers for Disease Control and Prevention has recommended that adults 60 and over be given the company's shingles vaccine Zostavax.</description>
    <link>http://www.ibtimes.com/articles/20080515/merck-shingles-vaccine-gets-cdc-recommendation.htm</link> 
  <pubDate>Thu, 15 May 2008 12:21:56 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Pharmaceuticals open lower</title>
  <description>Shares of large pharmaceutical companies opened mostly lower Thursday as the broader market saw a mixed opening on a government report of higher jobless claims and a report that industrial production dropped by more than expected in April.</description>
    <link>http://www.ibtimes.com/articles/20080515/opening-glance-pharmaceuticals-open-lower.htm</link> 
  <pubDate>Thu, 15 May 2008 10:12:01 EDT</pubDate>
  </item>


  <item>
  <title>Merck says appeals court overturns Vioxx verdict</title>
  <description>A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck &amp; Co. in one of the few trials it lost over its withdrawn painkiller Vioxx.</description>
    <link>http://www.ibtimes.com/articles/20080514/merck-says-appeals-court-overturns-vioxx-verdict.htm</link> 
  <pubDate>Wed, 14 May 2008 21:00:44 EDT</pubDate>
  </item>


  <item>
  <title>Merck says appeals court overturns verdict in Vioxx case</title>
  <description>A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck &amp;amp; Co. in a case involving its withdrawn painkiller Vioxx. A Texas jury in April 2006 awarded the widow of 71-year-old Leonel Garza $32 million. That later was cut to about $7.75 million under Texas damage caps.</description>
    <image>
  <url>http://www.ibtimes.com/data/articleimgs/46288-merck.jpg</url>
  <link>http://www.ibtimes.com/articles/20080514/merck-says-appeals-court-overturns-verdict-vioxx-case.htm</link>
  </image>
    <link>http://www.ibtimes.com/articles/20080514/merck-says-appeals-court-overturns-verdict-vioxx-case.htm</link> 
  <pubDate>Wed, 14 May 2008 14:30:12 EDT</pubDate>
  </item>


  <item>
  <title>Merck says appeals court overturns verdict in Vioxx verdict</title>
  <description>Merck &amp; Co. says a Texas appeals court has overturned a verdict against the drugmaker in a case involving its withdrawn painkiller Vioxx. A Texas jury two years ago awarded the widow of 71-year-old Leonel (LAY'-oh-nel) Garza $32 million. That later was cut to about $7.75 million under Texas damage caps.</description>
    <link>http://www.ibtimes.com/articles/20080514/merck-says-appeals-court-overturns-verdict-in-vioxx-verdict.htm</link> 
  <pubDate>Wed, 14 May 2008 13:52:34 EDT</pubDate>
  </item>


  <item>
  <title>Investor reaches for reins on executive pay</title>
  <description>Some of Robert Morse's ideas are small: Paint a baseball so it's easier to read a curve. Make a four-colored deck of cards so his wife doesn't confuse the spades and clubs.</description>
    <image>
  <url>http://www.ibtimes.com/data/articleimgs/45567-executive-compensation-activist.jpg</url>
  <link>http://www.ibtimes.com/articles/20080512/investor-reaches-for-reins-on-executive-pay.htm</link>
  </image>
    <link>http://www.ibtimes.com/articles/20080512/investor-reaches-for-reins-on-executive-pay.htm</link> 
  <pubDate>Mon, 12 May 2008 12:41:18 EDT</pubDate>
  </item>


  <item>
  <title>Merck, India's Ranbaxy team up to find new drugs</title>
  <description>Two of the biggest pharmaceutical companies in the United States and India are teaming up to develop new anti-infective medications. Merck &amp; Co. of Whitehouse Station, N.J., and Ranbaxy Laboratories Ltd. of Gurgaon, India, announced Monday they have signed a product development deal.</description>
    <link>http://www.ibtimes.com/articles/20080512/merck-indias-ranbaxy-team-up-to-find-new-drugs.htm</link> 
  <pubDate>Mon, 12 May 2008 10:09:34 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Pharmaceutical stocks finish lower</title>
  <description>Shares of large pharmaceutical companies closed lower Friday as the broader market tumbled over wider-than-expected losses at insurer American International Group Inc. and a spike in oil prices.</description>
    <link>http://www.ibtimes.com/articles/20080509/closing-glance-pharmaceutical-stocks-finish-lower.htm</link> 
  <pubDate>Fri, 09 May 2008 16:40:10 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Pharmaceutical shares open lower</title>
  <description>Shares of large pharmaceutical companies opened lower Friday as the broader market tumbled over wider-than-expected losses at insurer American International Group Inc. and a spike in oil prices.</description>
    <link>http://www.ibtimes.com/articles/20080509/opening-glance-pharmaceutical-shares-open-lower.htm</link> 
  <pubDate>Fri, 09 May 2008 10:07:00 EDT</pubDate>
  </item>


  <item>
  <title>Drug companies defend TV advertisements before Congress</title>
  <description>Some of the nation's largest pharmaceutical companies defended their TV advertisements Thursday from Democrats pushing for tougher marketing restrictions.</description>
    <link>http://www.ibtimes.com/articles/20080508/drug-companies-defend-tv-advertisements-before-congress.htm</link> 
  <pubDate>Thu, 08 May 2008 16:55:45 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Pharmaceuticals gain with broader market</title>
  <description>Shares of large pharmaceutical companies closed mostly higher Thursday with the broader market, despite the appearance before Congress of executives from several major companies aiming to defend their advertising practices.</description>
    <link>http://www.ibtimes.com/articles/20080508/closing-glance-pharmaceuticals-gain-with-broader-market.htm</link> 
  <pubDate>Thu, 08 May 2008 16:40:38 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Pharmaceuticals</title>
  <description>Shares of large pharmaceutical companies opened higher Thursday as the broader market rose on reports of better-than-expected April retail sales. Here's how some key drug makers performed Thursday morning:</description>
    <link>http://www.ibtimes.com/articles/20080508/opening-glance-pharmaceuticals.htm</link> 
  <pubDate>Thu, 08 May 2008 10:05:56 EDT</pubDate>
  </item>


</channel>
</rss>